Showing results (111-120 of 762) with videos related to
Sort By:
Pageof 77
Biorheology|November 28, 2002
Radial artery wall shear stress evaluation in patients with arteriovenous fistula for hemodialysis accessAndrea Remuzzi, Bogdan Ene-Iordache, Lidia Mosconi, et al.The Lancet. Diabetes & Endocrinology|March 14, 2014
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trialAneliya Parvanova, Irene M van der Meer, Ilian Iliev, et al.Journal of the American Society of Nephrology : JASN|December 8, 2004
Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial resultsGiuseppe Remuzzi, Piero Ruggenenti, Annalisa Perna, et al.Frontiers in Immunology|July 19, 2021
Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration PlasmapheresisDiego Curtò, Federica Tomatis, Sara Gastoldi, et al.Acta Diabetologica|October 14, 2021
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trialFabiola Carrara, Piero Ruggenenti, Annalisa Perna, et al.Journal of Ophthalmology|July 15, 2010
Effect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: a prespecified analysis of the benedict trialPiero Ruggenenti, Ilian Iliev, Marco Filipponi, et al.The New England Journal of Medicine|November 2, 2004
Preventing microalbuminuria in type 2 diabetesPiero Ruggenenti, Anna Fassi, Anelja Parvanova Ilieva, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2016
Long-term Effects of Octreotide on Liver Volume in Patients With Polycystic Kidney and Liver DiseaseAntonio Pisani, Massimo Sabbatini, Massimo Imbriaco, et al.Journal of the American Society of Nephrology : JASN|May 11, 2017
Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous NephropathyJan A J G van den Brand, Piero Ruggenenti, Antonietta Chianca, et al.Journal of the American Society of Nephrology : JASN|May 28, 2009
ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcomeDario Cattaneo, Piero Ruggenenti, Sara Baldelli, et al.Pageof 77